Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

Arena Pharmaceuticals Inc (ARNA) Trade Now » Rate ARNA - Discuss ARNA - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

65.0%

Top:

50.0%

Rate ARNA:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

ARNA: Bull or Bear?

From: SocialPicks | Blogsphere | All

SocialPicks Community

BIG STOCK TO GET ARNA

21%

shares gained 7.9% after the company said its first-quarter loss widened, due in part to costs related to the Phase III lorcaserin Bloom trial. The first quarter of 2006 also included a $5 million milestone payment under its collaboration with Ortho-McNeil Pharmaceutical Inc. The San Diego biotechnology company had a first-quarter loss of $31.4 million, or 53 cents a share, compared with a loss of $12.7 million, or 30 cents a share, a year earlier. Arena said revenue for the quarter fell 60% to $4.91 million from $12.1 million a year earlier. This company is going to shoot up big. Look at a...

Continue reading »

By MoneyMaker314 (-19.20% risk: aggressive) 04/23/07

Comment

Bullish on ARNA ... ARNA

63%

bottom fishing!

Continue reading »

By Seven L (+9.39% risk: aggressive) 09/15/06

Comment

« previous
1
2
3
« next

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
NVDA	NVIDIA Corp
PG	The Procter & Gamble Company
DRYS	DryShips Inc.
POT	Potash Corp. of Saskatchewan Inc.
C	Citigroup Inc
AAPL	Apple Computer Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

StreetInsider.com on ARNA

Visit streetinsider.com

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Arena Pharmaceuticals Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.